BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38712289)

  • 1. Generation of a zebrafish neurofibromatosis model via inducible knockout of
    Rajan ARD; Huang Y; Stundl J; Chu K; Irodi A; Yang Z; Applegate BE; Bronner ME
    bioRxiv; 2024 Apr; ():. PubMed ID: 38712289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
    Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
    Sainz J; Huynh DP; Figueroa K; Ragge NK; Baser ME; Pulst SM
    Hum Mol Genet; 1994 Jun; 3(6):885-91. PubMed ID: 7951231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
    Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
    Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors.
    Louis DN; Ramesh V; Gusella JF
    Brain Pathol; 1995 Apr; 5(2):163-72. PubMed ID: 7670657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and Use of Merlin-Deficient Human Schwann Cells for a High-Throughput Chemical Genomics Screening Assay.
    Petrilli AM; Fernández-Valle C
    Methods Mol Biol; 2018; 1739():161-173. PubMed ID: 29546707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.
    Ruggieri M; Praticò AD; Evans DG
    Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis and associated tumour suppressor genes.
    Zwarthoff EC
    Pathol Res Pract; 1996 Jul; 192(7):647-57. PubMed ID: 8880865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
    Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis type 2 (NF2): a clinical and molecular review.
    Evans DG
    Orphanet J Rare Dis; 2009 Jun; 4():16. PubMed ID: 19545378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of vestibular schwannomas.
    Chang LS; Welling DB
    Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the neurofibromatosis 2 gene promoter expression during embryonic development.
    Akhmametyeva EM; Mihaylova MM; Luo H; Kharzai S; Welling DB; Chang LS
    Dev Dyn; 2006 Oct; 235(10):2771-85. PubMed ID: 16894610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
    Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
    J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
    Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
    J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.